SHARE-BASED COMPENSATION

9 Months Ended

Sep. 29, 2024

Share-Based Payment Arrangement [Abstract]

SHARE-BASED COMPENSATION

Stock Options

For the thirteen week periods ended September 29, 2024 and October 1, 2023, the Company recognized $0.2 million and $0.1 million of compensation expense related to stock options. For the thirty-nine week periods ended September 29, 2024 and October 1, 2023, the Company recognized $0.4 million of compensation expense related to stock options. Unamortized share-based compensation expense as of September 29, 2024 amounted to $0.7 million which is expected to be recognized over the next 2.4 years. As of September 29, 2024, a total of 1.1 million shares remain available for issuance under 2013 Plan.

A summary of stock option activity is presented as follows:


	Number of Shares	Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life	Total Intrinsic Value of Awards (in thousands)
Options outstanding at December 31, 2023	922,310	$	15.30	6.0	$	104
Granted	40,000	8.80
Exercised	(38,798)	6.74
Forfeited / Canceled	(3,650)	11.70
Options outstanding at September 29, 2024	919,862	$	15.40	5.5	$	—

Options exercisable at December 31, 2023	663,740	$	16.84	5.0	$	103
Options exercisable at September 29, 2024	729,926	$	16.59	4.8	$	—


	Number of Shares	Weighted Average Grant Date Fair Value
Nonvested outstanding at December 31, 2023	258,570	$	7.84
Nonvested outstanding at September 29, 2024	189,936	$	7.97

Restricted Stock

For the thirteen week periods ended September 29, 2024 and October 1, 2023, the Company recognized $0.1 million and $0.3 million of compensation expense related to restricted stock awards. For the thirty-nine week periods ended September 29, 2024 and October 1, 2023, the Company recognized $0.4 million and $0.5 million of compensation expense related to restricted stock awards. Unamortized share-based compensation expense as of September 29, 2024 amounted to $0.5 million which is expected to be recognized over the next 1.9 years.